Drugs / 1018 ISS-HBsAg
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00498212 | Jul 2007 → Aug 2008 | hepatitis B virus infection | Dynavax Technologies Corporation | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 1018 ISS-HBsAg | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00498212 ↗ |